KR20020094269A - Feed containing beta-glucan to stimulate the growth of fish - Google Patents

Feed containing beta-glucan to stimulate the growth of fish Download PDF

Info

Publication number
KR20020094269A
KR20020094269A KR1020010031885A KR20010031885A KR20020094269A KR 20020094269 A KR20020094269 A KR 20020094269A KR 1020010031885 A KR1020010031885 A KR 1020010031885A KR 20010031885 A KR20010031885 A KR 20010031885A KR 20020094269 A KR20020094269 A KR 20020094269A
Authority
KR
South Korea
Prior art keywords
fish
glucan
feed
beta
growth
Prior art date
Application number
KR1020010031885A
Other languages
Korean (ko)
Inventor
정경희
최원아
배승철
Original Assignee
주식회사 더멋진 바이오텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 더멋진 바이오텍 filed Critical 주식회사 더멋진 바이오텍
Priority to KR1020010031885A priority Critical patent/KR20020094269A/en
Publication of KR20020094269A publication Critical patent/KR20020094269A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/80Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/50Polysaccharides, gums
    • A23V2250/502Gums
    • A23V2250/5034Beta-Glucan

Abstract

PURPOSE: Feed obtained by adding beta-glucan produced from microorganism to conventional feed is provided which increases the growth rate of a fish and reduces the death rate thereof against pathogenic bacteria by enhancing immunity. CONSTITUTION: The feed for promotion of fish growth contains 0.01 to 0.1% by weight of beta-glucan produced by Agrobacterium or Alcaligenes faecalis. For example, 0.05% by weight of beta-glucan is fed to a fry of Sebastes schlegeli in an aquarium for 6 weeks and shows an enhanced growth rate.

Description

어류의 생장을 촉진시키는 베타글루칸을 포함한 사료{Feed containing beta-glucan to stimulate the growth of fish}Feed containing beta-glucan to stimulate the growth of fish

어류양식에 있어서 종묘생산 기술 및 고밀도 사육기술이 진보함에 따라 조피볼락, 넙치, 방어, 참돔, 돌돔 및 자주복 등의 여러 종류 어종의 대량생산이 이루어지고 있다. 이들 어종의 종묘생산 및 양성과정에 있어서 수많은 세균성 질병, 바이러스성 질병 및 기생충성 질병은 커다란 문제로 대두되고 있다. 특히, 근래 들어서 급속한 양식업의 팽창과 더불어 고밀도 사육과 같은 인위적 양식환경은 자연상태의 어류에서 크게 피해가 없었던 많은 질병 발생을 유발함으로써 막대한 경제적 손실을 초래하고 있다.As fishery production technology and high-density breeding technology advance in fish farming, mass production of various kinds of fish such as shellfish rock, flounder, yellowtail, red snapper, sea bream, and self-propelled fish is being produced. Numerous bacterial diseases, viral diseases and parasitic diseases are a big problem in the production and formation of these fish species. In particular, the recent rapid expansion of aquaculture and artificial aquaculture environments such as high-density farming have caused enormous economic losses by causing many diseases that have not been significantly damaged in natural fish.

이와 같은 양식 어류의 질병을 방지하기 위하여 항생물질이나 화학합성 약품, 성장 호르몬 및 첨가물을 다량 투여하거나 먹이와 이들 약제를 혼합한 것을 투여하여 왔다. 그러나, 상기 종래의 항생물질 등 첨가물을 투여하는 방법은 비용 면에서 경제적이지 못할 뿐 아니라, 양식어의 체내에 항생제 등이 축적되어 인간이 이를 섭취하는 경우 안전성에 문제가 있고 내성균의 출현도 우려된다.In order to prevent diseases of farmed fish, a large amount of antibiotics, chemical synthetic drugs, growth hormones and additives have been administered, or a mixture of food and these drugs has been administered. However, the conventional method of administering additives, such as antibiotics, is not only economical in terms of cost, but also accumulates antibiotics in the body of the farmed fish, causing problems in safety and the appearance of resistant bacteria. .

이러한 실정에 비추어 보면, 어류가 질병에 걸렸을 때의 치료보다는 질병에 걸리지 않도록 미연에 예방하는 것이 최상의 방법이라 할 수 있다. 생체의 면역체계를 활성화시켜 질병의 발생을 미리 예방하고자 하는 면역증강물질이 개발되어 왔는데 이러한 면역증강물질의 예로서 세균 세포벽 유래 펩티드 글리칸(일본 특개평10-229831), 세균, 효모로부터 얻어진 글루칸 등이 알려져 있다. 이러한 글루칸들의 대부분은 효모에서 얻어지고 있는데 효모의 세포벽에서 추출한 글루칸과 만노프로테인을 포함한 효모제제는 가축의 면역체계를 활성화시켜 체중을 증가시키는 효과(대한민국 특허공개번호 1999-0063361)를 보였다. 일본특개평 7-51000은 오레오바시디움속에 의하여 생산된 β1,3 글루칸을 주쇄로 한 다당으로 된 양식어용 사료첨가제에 대하여 개시하면서, 0.1∼5%의 농도로 β1,3 글루칸을 첨가하는 경우 어류의 체중이 증가하고 생존율의 증가에도 효과가 있다고 보고하고 있다.In light of this situation, it is best to prevent fish from becoming diseased rather than treating it when it is diseased. Immunopotentiators have been developed to activate the immune system of the living body to prevent disease outbreaks. Examples of such immunopotentiators are glucans obtained from bacterial cell wall-derived peptide glycans (Japanese Patent Application Laid-Open No. 10-229831), bacteria and yeast. Etc. are known. Most of these glucans are obtained from yeast, and yeast preparations including glucans and mannoproteins extracted from the cell walls of yeast have been shown to increase the body weight by activating the immune system of domestic animals (Korean Patent Publication No. 1999-0063361). Japanese Patent Laid-Open No. 7-51000 discloses a polysaccharide feed additive for aquaculture fish whose β1,3 glucan is produced by the genus Oreobasidium, while adding β1,3 glucan at a concentration of 0.1 to 5%. Is reported to have an effect on weight gain and survival.

일반적으로 효모 세포벽 유래 글루칸은 효모 세포벽이 극히 견고하고 소화하기 어려워 가축이나 어류의 글루칸 이용율이 낮은 단점이 있다. 이를 해결하기 위해서는 화학적·생물학적으로 분해해야 하고 함유량이 적은 성분을 추출 정제하는 공정이 필요하므로 고가로 공급될 수밖에 없는 실정이다. 따라서 이러한 글루칸을 효율적으로 분리하여 효과를 높이고 흡수되기 어려운 면역증강물질의 흡수를 돕기위한 기술들이 보고되어 있다(대한민국 특허공개번호 1999-028736).In general, yeast cell wall-derived glucan has a disadvantage in that the yeast cell wall is extremely hard and difficult to digest and thus has low utilization rate of glucan in livestock or fish. In order to solve this problem, it is necessary to decompose chemically and biologically, and a process of extracting and refining a low content component is inevitably provided at a high price. Therefore, techniques for efficiently separating these glucans to enhance the effect and aid in the absorption of immune enhancing substances that are difficult to be absorbed have been reported (Korean Patent Publication No. 1999-028736).

이러한 점에서 세포밖으로 분비되는 베타글루칸을 생산하는 미생물을 이용하면 간단하게 분리할 수 있으며 분해를 위한 처리를 별도로 하지 않아도 되는 등 생산공정이 간단하여 상대적으로 저가로 공급될 수 있다는 장점이 있다. 세포 밖으로 베타글루칸을 생산하는 미생물로서 오레오바시디움속 균주(일본 특개평7-51000)는 베타 1,3 과 1,6 결합이 섞여 있는 베타글루칸을 생산하며, 애그로박테리움 (Agrobacterium)속 균주는 베타-1,3 결합만을 가진 커드란 타입의 베타글루칸을 생산한다. 어류 양식에 있어서 이러한 직선 상의 구조를 갖는 베타글루칸(커드란)이 0.05∼5중량%인 양식용 사료 조성물을 이용하였을 때 면역능 증강과 병원균 공격실험에 대한 생잔율이 증가함(일본특허 공개번호 :1998-313794)을 통해 양식용 사료첨가제로 사용할 수 있음을 밝혔다.In this regard, microorganisms producing betaglucan secreted out of the cell can be easily separated and the production process can be supplied at a relatively low cost, such as a separate process for decomposition. As a microorganism producing beta glucan out of the cell, Oreobashidium strain (JP-A-7-51000) produces beta glucan mixed with beta 1,3 and 1,6 bonds, and Agrobacterium sp. Produces betaglucan of curdlan type with only beta-1,3 binding. When using aquaculture feed composition containing 0.05 to 5% by weight of beta glucan (curdlan) having such a linear structure in fish farming, the survival rate of the immune system is increased and the pathogen attack test is increased (Japanese Patent Publication No. 1998-313794) can be used as a feed additive for aquaculture.

위와 같이 기존의 특허문헌이나 보고에서는 베타 글루칸의 면역증강 물질로서의 긍정적인 측면만을 강조하여 왔다. 그런데 본 발명자들이 다양하고 정밀한 사양 실험을 수행한 결과 과량의 베타글루칸은 오히려 어류의 생장을 억제함을 발견하였으며 면역 반응에서도 부정적인 결과를 보여주었다.As described above, the existing patent literature or report has emphasized only the positive side of the beta glucan as an immune enhancing substance. However, as a result of the present inventors performing various precise specification experiments, the inventors found that excessive beta glucan inhibited the growth of fish and showed negative results in the immune response.

따라서 본 발명의 목적은 어류의 생장촉진 효과를 극대화하고 면역기능을 강화하여 병원균의 침입이나 스트레스로부터 생체를 보호해 줄 수 있는 글루칸의 최적 농도를 밝히고, 이를 이용한 어류용 사료 조성물을 제공하려는 것이다.Therefore, an object of the present invention is to maximize the growth promoting effect of fish and to enhance the immune function to find the optimal concentration of glucan that can protect the living body from invasion or stress of pathogens, and to provide a feed composition for fish using the same.

도 1은 에드워드시엘라 타르다(Edwardsiella tarda)로 공격실험 뒤 각 사료구별 누적 폐사율을 그래프로 나타낸 것.1 is a graph showing the cumulative mortality of each feed segment after the attack experiment with Edwardsiella tarda ( Edwardella tarda) .

상기 목적을 달성하기 위하여 본 발명에서는 베타글루칸, 특히 애그로박테리움(Agrobacterium) 속 또는 알칼리제네스 패칼리스(Alcaligenes faecalis) 균주가 생산하는 베타글루칸을 면역증강 등의 목적으로 양어용 사료에 첨가하여 이용하였다. 탄소원으로 설탕 또는 원당을, 질소원으로 염화암모늄을, 그리고 기타 무기염을 배지조성으로 하는 발효배지에서 아그로박테리움을 배양하여 베타글루칸을 생산하였다. 본 발명에서는 배양액을 농축, 건조하여 분말로 만들어 사용하였으며 배양액 자체를 사용하거나 정제하여 건조된 분말을 사용할 수도 있다.In the present invention to achieve the above object, beta glucan, Especially AgrobacteriumAgrobacterium) Or Alkaliness Packalis (Alcaligenes faecalisBeta glucan produced by the strain was added to fish farming for the purpose of immune boosting. Betaglucan was produced by culturing Agrobacterium in a fermentation broth in which medium was composed of sugar or raw sugar as a carbon source, ammonium chloride as a nitrogen source, and other inorganic salts. In the present invention, the culture solution is concentrated and dried to use powder, and the culture solution itself may be used or purified powder may be used to dry the powder.

본 발명은 애그로박테리움 속 또는 알칼리제네스 패칼리스 균주로부터 생산된 베타 글루칸을 건조사료 중량당 0.01 - 0.1중량% 포함한 어류용 사료 조성물에 관한 것이다.The present invention relates to a feed composition for fish comprising 0.01-0.1% by weight of beta glucan produced from Agrobacterium sp.

이하, 실시예에서는 조피볼락(우럭)과 넙치(광어)의 치어를 사육한 결과를 통해 본 발명을 상세히 설명한다. 하기 실시예는 본 발명을 구체적으로 예시하는 것일 뿐, 본 발명의 내용이 실시예에 의해 한정되는 것은 아니며 다른 어종이나 장기간의 사육 기간동안에도 적용될 수 있다.Hereinafter, the present invention will be described in detail through the result of breeding the larvae of the rockfish (Urug) and flounder (flatfish). The following examples merely illustrate the present invention in detail, and the content of the present invention is not limited by the examples, and may be applied to other fish species or long breeding periods.

먼저, 본 발명에 사용된 베타 글루칸은 아그로박테리움에 설탕을 탄소원으로 사용하고, 염화암모늄을 질소원으로, 그리고 기타 무기물을 포함하는 발효배지에서 배양하여 생산하였다. 발효가 완료된 후 베타 글루칸은 불용성 상태로 존재한다.베타 글루칸은 중성의 용액상태에서는 녹지 않기 때문에 발효액 중의 베타 글루칸을 세포와 분리하기 위해 배양액을 염기화시켜 베타 글루칸을 용해시킨 후 원심분리 또는 필터에 의해 세포를 제거한다. 이 용액을 수용성 유기용매와 접촉시키거나 용액을 중성화시킴으로써 베타 글루칸을 침전시킨 후 원심분리하고 이것을 건조시켜 정제된 분말을 얻는다. 베타 글루칸은 위와 같이 정제되거나 정제되지 않은 형태로도 사용될 수 있다. 본 발명의 실시예에서는 상기 방법으로 정제된 분말형을 사용하였다.First, the beta glucan used in the present invention was produced by culturing in a fermentation broth containing sugar as a carbon source, ammonium chloride as a nitrogen source, and other minerals in Agrobacterium. After fermentation is complete, beta glucan is insoluble.Beta glucan is insoluble in neutral solution, so to separate beta glucan from fermentation broth from cells, the culture medium is basified to dissolve beta glucan, followed by centrifugation or filter. Remove cells. Beta glucan is precipitated by contacting this solution with a water-soluble organic solvent or by neutralizing the solution, followed by centrifugation and drying to obtain a purified powder. Beta glucan can also be used in purified or unpurified form as above. In the embodiment of the present invention was used a powder form purified by the above method.

실시예 1 : 조피볼락(우럭) 사양시험Example 1: Zigbolak (Urug) Specification Test

실험어류는 조피볼락 치어를 실험시작시까지 상품사료를 공급하면서 2주간 예비사육을 실시하였다. 2주간 예비사육 후, 평균무게 4.0 g의 조피볼락 치어를 100ℓ 원형수조에 20마리씩 사료구 3반복으로 무작위 배치하였다.Experimental fish were fed two weeks of pre-fishing while feeding bokbolak fry until the start of the experiment. After 2 weeks of preliminary breeding, an average weight of 4.0 grams of juvenile rockfish larvae was randomly placed in a 100 L round water tank with 3 repetitions of feed.

사육수는 고속모래여과기(역여과 방식)에 의해 여과된 해수를 사용하였으며, 각 실험수조는 유수식으로 유수량은 실험 시작시에 2ℓ/min 되도록 하였다. 수온은 20∼22℃로 실험기간 동안 자연수온에 의존하였으며, 실험기간은 6주간 실시하였다.Breeding water was used seawater filtered by a high-speed sand filter (reverse filtration method), each of the experimental tank was flown water flow rate was 2ℓ / min at the beginning of the experiment. The water temperature was 20 ~ 22 ℃ and depended on the natural water temperature during the experiment. The experiment was carried out for 6 weeks.

실험사료내 베타글루칸의 첨가농도는 글루칸이 첨가되는 않은 사료구를 대조구로 하여 0.05%, 0.10%, 0.25% 및 0.5%의 4가지 농도로 첨가하였다.The concentrations of beta glucan in the experimental feed were added in four concentrations of 0.05%, 0.10%, 0.25% and 0.5% using the control group without glucan.

베타글루칸의 조피볼락 성장에 대한 영향Effect of Beta Glucan on Growth of Rockball Rocks

6주동안 베타글루칸을 공급하면서 행한 실험 결과는 표 1에 나타내었다. 글루칸 0.05%를 공급한 사료구가 대조구와 비교하여 유의적으로 높은 경향을 나타내었으나 0.1%를 공급한 사료구와 비교하여 유의적인 차이를 보이지 않았다. 0.25%를 공급하였을 때 대조구와 비슷하였으며 0.5%를 공급한 사료구에서 가장 낮은 성장률을 보였다.Table 1 shows the results of the experiments performed with beta glucan for 6 weeks. Feed group fed 0.05% glucan showed a significantly higher trend than control group, but showed no significant difference compared to feed group fed 0.1%. Feeding 0.25% was similar to the control and showed the lowest growth rate in the feed fed 0.5%.

이것은 베타글루칸이 과량으로 공급되면 오히려 생장을 저해함을 보여주는 것이다.This suggests that excessive supply of betaglucan inhibits growth.

대조구Control 0.05%0.05% 0.1%0.1% 0.25%0.25% 0.5%0.5% 증체율Weight gain 385385 405405 390390 380380 360360

1증체율 : (최종무게- 초기무게)×100 / 초기무게. 1 Growth Rate: (Final Weight-Initial Weight) × 100 / Initial Weight.

비특이적 면역반응 검사 및 평가Nonspecific Immune Response Test and Evaluation

두신 식세포의 활성분석을 위하여 실험사료 투여 종료 후 각 실험구에서 3마리씩의 어류를 무작위로 잡아서 두신을 분리하였다. 퍼콜 농도구배 원심분리(Percoll gradient centrifuge)를 이용하여 두신으로부터 식세포를 분리한 다음 식세포의 수를 1x106cells/ml 로 맞추었다. 그 다음 루미놀(luminol) 0.7ml과 세포 0.4ml을 큐벳(cuvette)에 넣은 후 5분간 인큐베이션(incubation)시킨 뒤 자이모산(zymosan)을 첨가한 후 루미네이터(luminometer_를 이용하여 화학발광 반응 (chemiluminescent(CL) response)을 측정하였다.For the analysis of the activity of the head cells, the heads were isolated by randomly catching three fish from each group after the end of the administration of the experimental feed. Phagocytic cells were separated from the head using Percoll gradient centrifuge, and the number of phagocytes was adjusted to 1 × 10 6 cells / ml. Next, 0.7 ml of luminol and 0.4 ml of cells were placed in a cuvette, followed by incubation for 5 minutes, followed by addition of zymosan, followed by chemiluminescent reaction using a luminometer. (CL) response) was measured.

라이소자임 활성(Lysozyme activity)은 Parry et al.(1965)의 turbidimetric method를 이용하여 측정하였다. 즉, 각 실험구에서 분리한 혈청을 마이크로코커스 라이소데익티커스(Micrococcus lysodeikticus)를 0.2 mg/ml의 농도로 0.05M 인산나트륨 완충용액(pH 6.2)에 현탁시킨 다음, 이 현탁액의 950㎕와 혈청 50㎕를 혼합하여 25℃에서 30초 및 4분 30초 간 반응시킨 후 흡광기(Spectrophotometer)(530 nm)를 이용하여 라이소자임 활성을 측정하였다. 라이소자임의 활성 단위는 분당 0.001의 흡광도 감소를 나타내는 효소의 양으로 정의하였다.Lysozyme activity was measured using the turbidimetric method of Parry et al. (1965). That is, the serum isolated from each experiment was suspended in 0.05M sodium phosphate buffer (pH 6.2) at a concentration of 0.2 mg / ml Micrococcus lysodeikticus , and then 950 μl of the suspension and serum 50 μl of the mixture was reacted at 25 ° C. for 30 seconds and 4 minutes 30 seconds, and then lysozyme activity was measured using a spectrophotometer (530 nm). The active unit of lysozyme was defined as the amount of enzyme that showed a decrease in absorbance of 0.001 per minute.

보체 대체 경로 (ACP) 활성은 양의 적혈구 세포(sheep red blood cells; SRBC)를 이용하여 분석하였다. SRBC를 Mg2+와 EGTA가 포함된 젤라틴 베로날 완충액(gelatin veronal buffer; GVB)에 3번 세척하고, 같은 완충액에서 2×108/ml로 조절하였다. 실험 혈청을 GVB를 이용하여 연속적으로 단계 희석한 후, SRBC를 100ℓ첨가하였다. 이 혼합액을 가끔씩 흔들어 주면서 20℃에서 90분간 배양한 후, 4℃에서 1600g로 원심분리하여 상층액을 분광 흡광도계의 흡광도 414nm에서 측정하였다. ACP (ACH50) 활성은 용혈의 정도에 따라 계산하였다.Complement Replacement Pathway (ACP) activity was analyzed using sheep red blood cells (SRBC). SRBC was washed three times in gelatin veronal buffer (GVB) containing Mg 2+ and EGTA, and adjusted to 2 × 10 8 / ml in the same buffer. The experimental serum was serially diluted with GVB followed by the addition of 100 L of SRBC. The mixture was incubated at 20 ° C. for 90 minutes with occasional shaking, followed by centrifugation at 1600 g at 4 ° C., and the supernatant was measured at 414 nm of the absorbance of the spectrophotometer. ACP (ACH50) activity was calculated according to the degree of hemolysis.

베타글루칸을 공급한 사료구는 대조구와 비교하였을 때, 보체 대체 경로의 활성(ACH50)과 혈청의 라이소자임(lysozyme) 활성 및 두신세포의 활성(CL) 반응에서 모든 사료구는 대조구보다 높은 경향을 보였다(표 2).Feeds fed with beta glucan showed a higher tendency in all feeds than control compared to control (ACH50), serum lysozyme (CL) activity, and cranial cell activity (CL). 2).

Peak value of CL (mV)Peak value of CL (mV) Lysozyme activity (U/ml)Lysozyme activity (U / ml) ACH50(U/ml)ACH50 (U / ml) 대조구Control 930930 570570 3636 0.05%0.05% 10401040 610610 4545 0.1%0.1% 950950 610610 4545 0.25%0.25% 10301030 600600 4141 0.5%0.5% 660660 580580 4848

병원성 미생물에 의한 공격 실험Attack experiment by pathogenic microorganism

실험 사료 투여 종료 후, 어체통과를 통해 독력을 강화시킨 에드워드시엘라 타르다(Edwardsiella tarda)를 이용하여 공격 실험을 하였다. 실험 균주는 1.5% NaCl이 첨가된 TSA배지에서 27℃, 48시간 배양한 후 집균하여, 생리식염수로 세균수를 1x106cfu/ml로 맞춘 후 0.1ml를 조피볼락의 복강에 주사하였다. 공격 실험의 결과는 누적 폐사율로 나타내었으며, 폐사된 개체의 신장을 TSA 배지에 도말하여 에드워드시엘라 타르다를 분리하여 확인하였다.After the administration of the experimental feed, the attack experiment was carried out using Edwardsiella tarda , which strengthened virulence through the passage of the fish. The experimental strains were incubated for 48 hours at 27 ° C. in TSA medium to which 1.5% NaCl was added, and the bacterial counts were adjusted to 1 × 10 6 cfu / ml with saline, and 0.1 ml was injected into the abdominal cavity of the zophyllolac. The results of the challenge experiments were expressed as cumulative mortality, and the kidneys of the dead individuals were smeared onto TSA medium to isolate Edwardsiella tarda.

에드워드시엘라 타르다를 접종한 공격실험에서 글루칸을 투여한 모든 사료구가 대조구에 비해 초기폐사율이 낮게 나타났다. 그리고, 글루칸 0.05% 첨가한 사료구가 대조구에 비해 통계적으로 유의하게 낮은 누적폐사율을 나타내었다(도 1).In the challenge experiments inoculated with Edward Siela tarda, all feeds treated with glucan showed lower initial mortality than the control. In addition, the feed group added 0.05% glucan showed statistically significantly lower cumulative mortality than the control group (FIG. 1).

실시예 2 : 넙치(광어) 사양시험Example 2 flounder (flatfish) specification test

실험어류를 넙치 치어로 하고 실험사료 내 베타글루칸의 첨가농도는 베타글루칸이 첨가되지 않은 사료구를 대조구로 하여 0.05%, 0.075%, 0.10%의 농도로 첨가하였다. 6주 동안 베타글루칸을 공급한 성장 실험 결과는 표 3에 나타내었다. 글루칸 0.075%를 공급한 사료구가 대조구와 비교하여 가장 높은 값을 보여주며 전체적으로는 예상했던 것처럼 베타글루칸을 급이한 실험구가 대조구에 비해 높은 성장률을 보였다.Experimental fish was added to the flounder and the concentration of beta glucan in the experimental feed was added at the concentrations of 0.05%, 0.075%, and 0.10% with the control group without beta glucan. Results of growth experiments in which beta glucan was supplied for 6 weeks are shown in Table 3. Feeds fed with 0.075% glucan showed the highest value compared to the control, and overall, the experimental group fed the beta glucan showed higher growth rate than the control.

대조구Control 0.05%0.05% 0.075%0.075% 0.1%0.1% 증체율(%)1 % Increase 1 277277 285285 295295 290290

1증체율 : (최종무게- 초기무게)×100 / 초기무게. 1 Growth Rate: (Final Weight-Initial Weight) × 100 / Initial Weight.

본 발명에서는 베타글루칸을 어류용 사료 첨가제로 사용하여 어류의 생장속도를 증가시키며 면역능을 강화하여 외부의 병원균 공격시에도 폐사율을 감소시킬 수 있다는 결과를 얻었다. 특히, 베타 글루칸은 건조사료에 대하여 0.01∼0.2%의 농도로 첨가하는 경우 증체율이 증가하며, 폐사율도 감소하는 효과를 나타내었다. 이러한 결과는 베타글루칸이 갖고 있는 면역증강능을 이용해서 외부의 질병으로부터 보호할 수 있는 자체 방어 능력을 증대시키는 동시에 어류의 생장을 촉진하여 양식업의 경제성을 증대할 수 있는 수단을 제공한다.In the present invention, beta glucan was used as a feed additive for fish to increase the growth rate of fish and enhance immunity to reduce mortality even when attacking external pathogens. In particular, when the beta glucan is added at a concentration of 0.01 to 0.2% with respect to the dry feed, the increase rate and the mortality rate also decreased. These results provide a means to increase the economics of aquaculture by increasing the self-defense ability to protect against external diseases by utilizing beta-glucan's immune enhancing ability.

Claims (2)

베타 글루칸을 건조사료 중량당 0.01 - 0.1중량% 포함하는 것을 특징으로 하는 어류생장 촉진용 베타 글루칸을 포함하는 사료.Feed containing beta glucan for promoting fish growth, characterized in that containing beta glucan 0.01 to 0.1% by weight per dry feed. 제1항에 있어서, 베타글루칸은 애그로박테리움 속 또는 알칼리제네스 패칼리스 균주로부터 생산된 것임을 특징으로 하는 어류생장 촉진용 베타 글루칸을 포함하는 사료.[Claim 2] The feed of claim 1, wherein the beta glucan is produced from the genus Agrobacterium or Alkali ness facalis strain.
KR1020010031885A 2001-06-08 2001-06-08 Feed containing beta-glucan to stimulate the growth of fish KR20020094269A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010031885A KR20020094269A (en) 2001-06-08 2001-06-08 Feed containing beta-glucan to stimulate the growth of fish

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010031885A KR20020094269A (en) 2001-06-08 2001-06-08 Feed containing beta-glucan to stimulate the growth of fish

Publications (1)

Publication Number Publication Date
KR20020094269A true KR20020094269A (en) 2002-12-18

Family

ID=27708169

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010031885A KR20020094269A (en) 2001-06-08 2001-06-08 Feed containing beta-glucan to stimulate the growth of fish

Country Status (1)

Country Link
KR (1) KR20020094269A (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0384323A1 (en) * 1989-02-20 1990-08-29 Taito Co., Ltd. Composition and process to enhance the efficacy of a fish vaccine
JPH0648949A (en) * 1992-07-30 1994-02-22 Taito Kk Biophylactic enhancer and feed containing the same for shellfish
JPH06172217A (en) * 1991-05-21 1994-06-21 Taito Kk Immune effect enhancer for vaccine
JPH06256199A (en) * 1993-03-05 1994-09-13 Nippon Paper Ind Co Ltd Immunopotentiator for feed and its production
JPH0750999A (en) * 1993-08-13 1995-02-28 Nippon Synthetic Chem Ind Co Ltd:The Feed additive for domestic animal
JPH0751000A (en) * 1993-08-13 1995-02-28 Nippon Synthetic Chem Ind Co Ltd:The Feed additive for cultured fish
JPH07184595A (en) * 1993-12-28 1995-07-25 Nippon Paper Ind Co Ltd Yeast extract composition and its production and feed containing the same
JPH10313794A (en) * 1997-05-21 1998-12-02 Takeda Chem Ind Ltd Feed composition for fish kind cultivation
KR19990028736A (en) * 1995-07-05 1999-04-15 티. 이. 카바나 Method for producing beta -glucan-mannanase by autolysis of cells under constant pH, temperature and time conditions
KR19990063361A (en) * 1997-12-23 1999-07-26 최윤재 Natural substance derived from yeast cell wall and use as an immunopotentiator

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0384323A1 (en) * 1989-02-20 1990-08-29 Taito Co., Ltd. Composition and process to enhance the efficacy of a fish vaccine
JPH06172217A (en) * 1991-05-21 1994-06-21 Taito Kk Immune effect enhancer for vaccine
JPH0648949A (en) * 1992-07-30 1994-02-22 Taito Kk Biophylactic enhancer and feed containing the same for shellfish
JPH06256199A (en) * 1993-03-05 1994-09-13 Nippon Paper Ind Co Ltd Immunopotentiator for feed and its production
JPH0750999A (en) * 1993-08-13 1995-02-28 Nippon Synthetic Chem Ind Co Ltd:The Feed additive for domestic animal
JPH0751000A (en) * 1993-08-13 1995-02-28 Nippon Synthetic Chem Ind Co Ltd:The Feed additive for cultured fish
JPH07184595A (en) * 1993-12-28 1995-07-25 Nippon Paper Ind Co Ltd Yeast extract composition and its production and feed containing the same
KR19990028736A (en) * 1995-07-05 1999-04-15 티. 이. 카바나 Method for producing beta -glucan-mannanase by autolysis of cells under constant pH, temperature and time conditions
JPH10313794A (en) * 1997-05-21 1998-12-02 Takeda Chem Ind Ltd Feed composition for fish kind cultivation
KR19990063361A (en) * 1997-12-23 1999-07-26 최윤재 Natural substance derived from yeast cell wall and use as an immunopotentiator

Similar Documents

Publication Publication Date Title
JP6763453B2 (en) Feed for fish farming
EP2754354B1 (en) Method for using a bacillus subtilis strain to enhance animal health
KR101536901B1 (en) Probiotics composition for fishes containing a mixture of Bacillus subtilis and phage
Zhenming et al. Marine yeasts and their applications in mariculture
Montero-Rocha et al. Immunostimulation of white shrimp (Litopenaeus vannamei) following dietary administration of Ergosan
Sealey et al. Overview of nutritional strategies affecting health of marine fish
WO2003103692A1 (en) Zooplankton enrichment with probionts and prebionts and uses thereof
KR101663570B1 (en) Feed additive containing Pyeong wee-San sludge extract and functional feed using thereof
KR20010071331A (en) Additives for crustacean or fish feeds and feeds
JP2000103740A (en) Drug and feed for fishes and shellfishes
CN1290429C (en) Infectious disease preventive/remedy for fishes and shellfishes
KR20020094269A (en) Feed containing beta-glucan to stimulate the growth of fish
KR20190007219A (en) Composition for immunity enhanvement feed additves of crustaceans and mammals, and method for producing thereof
JPH10117701A (en) Poly-gamma-glutamic acid-containing feed composition
CN114075519A (en) Paenibacillus graveolens and application thereof in prawn culture and medicine preparation
JPH1160495A (en) Medicine for preventing disease for immune system immature animal
JP4294326B2 (en) Agents for preventing and / or treating seafood infections
JPH06263649A (en) Immunopotenitator
JPH0699315B2 (en) Weight gain and immunopotentiator, method for producing the same, and feed containing the same
WO2019181527A1 (en) Immunopotentiating agent
JP2008285431A (en) Composition for preventing and treating viral infectious disease of cultured fish
JPH10229831A (en) Method for immune activation of crustacean, and feed additive
Ahmad et al. Interaction of low‐level dietary supplementation of Chlorella vulgaris Beijerinck, 1890, and feeding duration on growth hormone, growth performance and serum biochemistry of red hybrid tilapia (Oreochromis mossambicus× Oreochromis niloticus)
JPH0751000A (en) Feed additive for cultured fish
KR0134559B1 (en) Preparation of lactobacillus containing organical bound zinc

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application